Redmile as of Dec. 31, 2015
Portfolio Holdings for Redmile
Redmile holds 57 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amicus Therapeutics (FOLD) | 7.5 | $100M | 10M | 9.70 | |
Medivation | 5.8 | $77M | 1.6M | 48.34 | |
Penumbra (PEN) | 5.7 | $76M | 1.5M | 49.57 | |
Array BioPharma | 5.6 | $75M | 18M | 4.22 | |
Intra Cellular Therapies (ITCI) | 4.9 | $66M | 1.2M | 53.79 | |
Clovis Oncology | 4.7 | $63M | 1.8M | 35.00 | |
Seattle Genetics | 4.6 | $62M | 1.4M | 44.88 | |
Teva Pharmaceutical Industries (TEVA) | 4.6 | $62M | 938k | 65.64 | |
Sage Therapeutics (SAGE) | 4.2 | $56M | 958k | 58.30 | |
Portola Pharmaceuticals | 3.7 | $49M | 958k | 51.45 | |
WellCare Health Plans | 3.3 | $44M | 563k | 78.21 | |
Ironwood Pharmaceuticals (IRWD) | 3.2 | $43M | 3.7M | 11.59 | |
Boston Scientific Corporation (BSX) | 3.1 | $42M | 2.3M | 18.44 | |
Pfizer Inc option | 3.0 | $41M | 1.3M | 32.28 | |
Atara Biotherapeutics (ATRA) | 3.0 | $41M | 1.5M | 26.41 | |
Incyte Corporation (INCY) | 2.9 | $39M | 358k | 108.45 | |
Diplomat Pharmacy | 2.9 | $38M | 1.1M | 34.22 | |
Nevro (NVRO) | 2.1 | $28M | 415k | 67.51 | |
Neuroderm Ltd F | 2.0 | $27M | 1.6M | 17.05 | |
Centene Corporation (CNC) | 2.0 | $27M | 408k | 65.81 | |
Insmed (INSM) | 1.9 | $25M | 1.4M | 18.15 | |
UnitedHealth (UNH) | 1.6 | $22M | 187k | 117.64 | |
Allergan | 1.6 | $22M | 69k | 312.50 | |
Model N (MODN) | 1.6 | $21M | 1.9M | 11.16 | |
Zeltiq Aesthetics | 1.5 | $20M | 709k | 28.53 | |
Nanostring Technologies (NSTG) | 1.5 | $20M | 1.4M | 14.71 | |
Wave Life Sciences (WVE) | 1.4 | $18M | 1.2M | 15.10 | |
Cytomx Therapeutics (CTMX) | 1.1 | $14M | 738k | 19.51 | |
Health Net | 0.9 | $12M | 181k | 68.46 | |
Endologix | 0.8 | $10M | 1.0M | 9.90 | |
Charles River Laboratories (CRL) | 0.7 | $9.8M | 122k | 80.39 | |
Oxford Immunotec Global | 0.7 | $9.9M | 860k | 11.50 | |
Trivascular Technologies | 0.7 | $9.7M | 1.5M | 6.65 | |
Fate Therapeutics (FATE) | 0.6 | $8.0M | 2.4M | 3.37 | |
Press Ganey Holdings | 0.6 | $7.6M | 240k | 31.55 | |
Blueprint Medicines (BPMC) | 0.6 | $7.3M | 277k | 26.34 | |
Global Blood Therapeutics In | 0.5 | $7.1M | 219k | 32.33 | |
DURECT Corporation | 0.4 | $5.8M | 2.6M | 2.21 | |
Invitae (NVTA) | 0.4 | $5.4M | 660k | 8.21 | |
Oncothyreon | 0.4 | $5.2M | 2.3M | 2.22 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.4 | $4.8M | 557k | 8.68 | |
Pfizer (PFE) | 0.3 | $4.0M | 124k | 32.28 | |
Array Biopharma Inc note 3.000% 6/0 | 0.3 | $3.7M | 4.0M | 0.93 | |
Eleven Biotherapeutics | 0.2 | $2.6M | 876k | 3.01 | |
Conformis | 0.2 | $2.2M | 126k | 17.29 | |
Celgene Corporation | 0.1 | $1.2M | 10k | 119.74 | |
iShares Dow Jones US Health Care (IHF) | 0.0 | $562k | 4.5k | 124.34 | |
Chemocentryx | 0.0 | $512k | 63k | 8.10 | |
D Fluidigm Corp Del (LAB) | 0.0 | $352k | 33k | 10.81 | |
Pronai Therapeutics | 0.0 | $373k | 25k | 15.05 | |
SPDR S&P Biotech (XBI) | 0.0 | $317k | 4.5k | 69.98 | |
Accelr8 Technology | 0.0 | $215k | 10k | 21.50 | |
Avalanche Biotechnologies In | 0.0 | $231k | 24k | 9.53 | |
Dbv Technologies S A (DBVT) | 0.0 | $290k | 8.0k | 36.28 | |
Aduro Biotech | 0.0 | $294k | 10k | 28.17 | |
Castlight Health | 0.0 | $44k | 10k | 4.30 | |
Aurinia Pharmaceuticals (AUPH) | 0.0 | $41k | 17k | 2.47 |